Oracea^® | Alcortin™ | Novacort™

Our Products

This section of this website is intended for use in the United States, its
territories, and Puerto Rico only. Other countries may have different
regulatory requirements related to product information.

CollaGenex currently markets products to the dermatological field of medicine. CollaGenex received approval of Oracea^® in May, 2006. Oracea is now commercially available.

The CollaGenex portfolio of products also includes co-marketed products, such as Alcortin™ and Novacort™ . Future dermatology products may be based on the unique properties of the SansRosa or IMPACS technology platforms or the Restoraderm drug delivery technology.

If you are a physician, pharmacist, or other healthcare provider
and have a question or need additional information about a CollaGenex
product, please call CollaGenex Pharmaceuticals Professional Affairs at
1-888-339-5678.

Home / Contact Us / Site Map / Press Releases / About Collagenex / Our Products
Investor Relations / Core Technologies / Business Development / Resources